Elevation of sympathetic activity by eprosartan in young male subjects

American Journal of Hypertension

Volumn 16, Issue 8, 2003, Pages 658-664

  Heusser, Karsten ^a   Vitkovsky, Jan ^a   Raasch, Walter ^b   Schmieder, Roland F ^a   Schobel, Hans P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

And neurohumoral control of the circulation; Angiotensin converting enzyme inhibitors angiotensin receptors; Autonomic; Cardiovascular pharmacology; Clinical studies; Reflex

Indexed keywords

ADRENALIN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; EPROSARTAN; NORADRENALIN; PLACEBO;

ADRENALIN BLOOD LEVEL; ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HEART STRESS; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NEUROGRAPHY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0041366817     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00917-8     Document Type: Article

References (35)

1. Noll G, Wenzel RR, de Marchi S, Shaw S, Lüscher TF: Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997;95:2286-2292.
2. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD: Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996;27:358-364.
3. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G: Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreftex control of circulation in heart failure. Circulation 1997;96:1173-1179.
4. Ligtenberg G, Blankestijn PJ, Oey L, Klein IHH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999;340:1321-1328.
5. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA: Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril. J Hypertens 2001;19:465-473.
6. Moreau N, Richer C, Vincent MP, Giudicelli JF: Sympathoinhibitory effects of losartan in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;22:126-134.
7. Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR Jr: Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 1997;55:244-251.
8. Wong PC, Bernard R, Timmermans PB: Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension 1992;19:663-667.
9. Dendorfer A, Raasch W, Tempel K, Dominiak P: Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 1998;93(Suppl):224-229.
10. Struck J, Muck P, Trübger D, Handrock R, Weidinger G, Dendorfer A, Dodt C: Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens 2002;20:1143-1149.
11. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.
12. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-1587.
13. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J: Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 1999;100:1056-1064.
14. Anonymous: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-183.
15. Whitney RJ: The measurement of volume changes in human limbs. J Physiol 1953;121:1-27.
16. Vallbo AB, Hagbarth KE: Impulses recorded with microelectrodes in human muscle nerves during stimulation of mechanoreceptors and voluntary contractions. Electroencephalogr Clin Neurophysiol 1967;23:389-396.
17. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG: Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919-957.
18. Schmieder RE, Langenfeld MR, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H: Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996;94:1304-1309.
19. Raasch W, Betge S, Dendorfer A, Schlecht T, Dominiak P: ACE inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats (SHR). J Hypertens 2001;19:1827-1833.
20. Goldsmith SR, Hasking GJ: Subpressor angiotensin II infusions do not stimulate sympathetic activity in humans. Am J Physiol 1990;258:H179-H182.
21. Goldsmith SR, Hasking GJ, Miller E: Angiotensin II and sympathetic nervous activity in patients with congestive heart failure. J Am Coll Cardiol 1993;21:1107-1113.
22. Goldsmith SR, Rector TS, Bank AJ, Garr M, Kubo SH: Effect of angiotensin II on noradrenaline release in the human forearm. Cardiovasc Res 1994;28:663-666.
23. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J, Zelis R: Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest 1994;93:684-691.
24. Shricker K, Holmer S, Kramer BK, Riegger GA, Kurtz A: The role of angiotensin II in the feedback control of renin gene expression. Pflugers Arch 1997;434:166-172.
25. Sanders JS, Ferguson DW: Diastolic pressure determines autonomic responses to pressure perturbations. J Appl Physiol 1989;66:800-807.
26. Heesch CM, Crandall ME, Turbek JA: Converting enzyme inhibitors cause pressure-independent resetting of baroreflex control of sympathetic outflow. Am J Physiol 1996;270:R728-R737.
27. Reid IA, Chou L: Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits. Endocrinology 1990;126:2749-2756.
28. Saigusa T, Iriki M, Arita J: Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla. Am J Physiol 1996;271:H1015-H1021.
29. Segar JL, Minnick A, Nuyt AM, Robillard JE: Role of endogenous ANG II and AT1 receptors in regulating arterial baroreflex responses in newborn lambs. Am J Physiol 1997;272:R1862-R1873.
30. May CN, McAllen RM: Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in concious sheep. Am J Physiol 1997;273:R560-R567.
31. Phillips MI: Functions of angiotensin in the central nervous system. Annu Rev Physiol 1987;49:413-435.
32. Guo GB, Abboud FM: Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 1984;246:H80-H89.
33. Lappe RW, Brody MJ: Mechanisms of the central pressor action of angiotensin II in conscious rats. Am J Physiol 1984;246:R56-R62.
34. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S, Shionoiri H, Ishii M: Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol 1991;261:R690-R696.
35. DiBona GF: Central sympathoexcitatory actions of angiotensin II: role of type I angiotensin II receptors. J Am Soc Nephrol 1999;10(Suppl 11):S90-S94.